Ashland Inc. (ASH) stock
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3025% above fair value
$76.47+1.20 (+1.59%)
Close on Nov 13, 2026Market cap $3.50BP/E –Yield 2.14%
Ashland r&d expenses
Research and development expenses are spending on new products and technology.
Ashland's R&D Expenses for the twelve months ending Jun 30, 2026 was $55.00M, up 3.8% year over year. For fiscal 2025 it was $54.00M, down 1.8% from the year before. Over ten years it grew -5.9% a year on average. The highest annual figure on record is $114.00M in fiscal 2014.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $54.00M | -1.8% |
| FY2024 | Sep 30, 2024 | $55.00M | +7.8% |
| FY2023 | Sep 30, 2023 | $51.00M | -7.3% |
| FY2022 | Sep 30, 2022 | $55.00M | +10.0% |
| FY2021 | Sep 30, 2021 | $50.00M | -10.7% |
| FY2020 | Sep 30, 2020 | $56.00M | -3.4% |
| FY2019 | Sep 30, 2019 | $58.00M | -20.5% |
| FY2018 | Sep 30, 2018 | $73.00M | 0.0% |
| FY2017 | Sep 30, 2017 | $73.00M | -16.1% |
| FY2016 | Sep 30, 2016 | $87.00M | -12.1% |
| FY2015 | Sep 30, 2015 | $99.00M | -13.2% |
| FY2014 | Sep 30, 2014 | $114.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $15.00M | +15.4% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $14.00M | 0.0% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $13.00M | 0.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $13.00M | 0.0% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $13.00M | -13.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $14.00M | 0.0% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $13.00M | +8.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $13.00M | -7.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $15.00M | +25.0% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $14.00M | +16.7% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $12.00M | -7.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $14.00M | -6.7% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $12.00M | -14.3% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $12.00M | -7.7% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $13.00M | 0.0% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $15.00M | +15.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $14.00M | +7.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $13.00M | +18.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $13.00M | 0.0% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $13.00M | +62.5% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $13.00M | -7.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $11.00M | -38.9% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $13.00M | -18.8% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $8.00M | +14.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $14.00M | -17.6% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $18.00M | +5.9% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $16.00M | -5.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $7.00M | -61.1% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $17.00M | -5.6% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $17.00M | -5.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $17.00M | -10.5% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $18.00M | +50.0% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $18.00M | -10.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $18.00M | -14.3% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $19.00M | -5.0% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $12.00M | -42.9% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $20.00M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $21.00M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $20.00M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $21.00M | – |
See a number that looks wrong?